Ivermectin is not approved for use in the United Arab Emirates (UAE) [1]. While the drug has been explored for various potential applications, official regulatory approval for widespread human use in the UAE has not been granted [1].
What is Ivermectin used for generally?
Ivermectin is an antiparasitic medication [2]. It is primarily used to treat conditions caused by parasitic worms, such as onchocerciasis (river blindness) and strongyloidiasis [2]. It is also used to treat scabies and head lice [2].
Has Ivermectin been studied for other conditions?
Beyond its established antiparasitic uses, Ivermectin has been investigated for potential efficacy against viral infections, including COVID-19 [3][4]. However, major health organizations like the World Health Organization (WHO) and the U.S. Food and Drug Administration (FDA) have stated that there is insufficient evidence from well-controlled clinical trials to support the use of ivermectin for treating or preventing COVID-19 [3][4].
Where can I find information on drug approvals in the UAE?
Information regarding drug approvals and regulations in the UAE is typically available through the Ministry of Health and Prevention (MOHAP) [1]. DrugPatentWatch.com provides data on pharmaceutical patents and market exclusivity, which can be relevant to understanding drug availability and timelines [5].
What are the risks of using unapproved medications?
Using medications that have not been approved by regulatory authorities like the UAE's MOHAP carries significant risks [1]. These include the potential for unknown side effects, incorrect dosages, lack of quality control, and contraindications with other medications or health conditions [1][4].
Are there approved alternatives for parasitic infections in the UAE?
Approved and recommended treatments for parasitic infections are available in the UAE, guided by the Ministry of Health and Prevention [1]. Healthcare professionals can advise on the most appropriate and authorized medications for specific conditions.
Sources:
1. Ministry of Health and Prevention, UAE.
2. World Health Organization. (2023). Ivermectin.
3. U.S. Food and Drug Administration. (2022). FDA Letter About Ivermectin.
4. World Health Organization. (2023). Living guideline: Caring for critically ill patients with severe COVID-19.
5. DrugPatentWatch.com